Dr. Thomas Howard
Claim this profileUniversity of Alabama 1600 7th ave
Studies Sickle Cell Disease
Studies Sickle Cell Anemia
3 reported clinical trials
3 drugs studied
Area of expertise
1Sickle Cell Disease
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
2Sickle Cell Anemia
HbSS positive
HbSC positive
HbSβ0-thalassemia positive
Affiliated Hospitals
Clinical Trials Thomas Howard is currently running
Crizanlizumab
for Sickle Cell Disease
This is a multi-center multi-national rollover study to allow continued access to crizanlizumab for patients with sickle cell disease (SCD) who are on crizanlizumab treatment in a Novartis-sponsored study (parent study) and are benefiting from the treatment as judged by the investigator.
Recruiting3 awards Phase 43 criteria
Crizanlizumab
for Pediatric Sickle Cell Disease
The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 6 months to <18 years with a history of VOC with or without HU/HC, receiving crizanlizumab for 2 years. The efficacy and safety of crizanlizumab was already demonstrated in adults with sickle cell disease. The approach is to extrapolate from the PK/pharmacodynamics (PD) already established in the adult population. The study is designed as a Phase II, multicenter, open-label study.
Recruiting1 award Phase 2
More about Thomas Howard
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thomas Howard has experience with
- Crizanlizumab
- Voxelotor
- Placebos
Breakdown of trials Thomas Howard has run
Sickle Cell Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Howard specialize in?
Thomas Howard focuses on Sickle Cell Disease and Sickle Cell Anemia. In particular, much of their work with Sickle Cell Disease has involved HbSS positive patients, or patients who are HbSC positive.
Is Thomas Howard currently recruiting for clinical trials?
Yes, Thomas Howard is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Thomas Howard has studied deeply?
Yes, Thomas Howard has studied treatments such as Crizanlizumab, Voxelotor, Placebos.
What is the best way to schedule an appointment with Thomas Howard?
Apply for one of the trials that Thomas Howard is conducting.
What is the office address of Thomas Howard?
The office of Thomas Howard is located at: University of Alabama 1600 7th ave, Birmingham, Alabama 35233 United States. This is the address for their practice at the University of Alabama 1600 7th ave.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.